alendronate has been researched along with Airflow Obstruction, Chronic in 5 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic obstructive pulmonary disease (COPD) and systemic glucocorticoid exposure are well-known risk factors of osteoporosis." | 1.39 | Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids. ( Abrahamsen, B; Brask-Lindemann, D; Eiken, P; Eskildsen, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peake, C | 1 |
| Trompeter, A | 1 |
| Vestergaard, P | 1 |
| Schwartz, K | 1 |
| Pinholt, EM | 1 |
| Rejnmark, L | 1 |
| Mosekilde, L | 1 |
| Brask-Lindemann, D | 1 |
| Eiken, P | 1 |
| Eskildsen, P | 1 |
| Abrahamsen, B | 1 |
| Smith, BJ | 1 |
| Laslett, LL | 1 |
| Pile, KD | 1 |
| Phillips, PJ | 1 |
| Phillipov, G | 1 |
| Evans, SM | 1 |
| Esterman, AJ | 1 |
| Berry, JG | 1 |
| Lau, EM | 1 |
| Woo, J | 1 |
| Chan, YH | 1 |
| Li, M | 1 |
2 trials available for alendronate and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Randomized controlled trial of alendronate in airways disease and low bone mineral density.
Topics: Absorptiometry, Photon; Aged; Alendronate; Asthma; Bone Density; Bone Density Conservation Agents; F | 2004 |
Alendronate for the prevention of bone loss in patients on inhaled steroid therapy.
Topics: Administration, Inhalation; Alendronate; Asthma; Bone Density; Double-Blind Method; Female; Glucocor | 2001 |
3 other studies available for alendronate and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Low-energy atypical femoral shaft and ipsilateral neck fracture: a rare association.
Topics: Aftercare; Aged; Alendronate; Bone Density Conservation Agents; Bone Plates; Bone Screws; Denosumab; | 2017 |
Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study.
Topics: Aged; Alendronate; Atrial Fibrillation; Atrial Flutter; Bone Density Conservation Agents; Cohort Stu | 2010 |
Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Case-Control Studies; Denmark; Drug Prescriptio | 2013 |